# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001640334-23-002227
Filing Date
2023-11-20
Accepted
2023-11-20 17:16:25
Documents
88
Period of Report
2023-08-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | lxrp_10k.htm iXBRL | 10-K | 1313526
2 | CONSENT | lxrp_ex231.htm | EX-23.1 | 2047
3 | CONSENT | lxrp_ex232.htm | EX-23.2 | 2483
4 | CERTIFICATION | lxrp_ex311.htm | EX-31.1 | 11499
5 | CERTIFICATION | lxrp_ex312.htm | EX-31.2 | 12025
6 | CERTIFICATION | lxrp_ex321.htm | EX-32.1 | 5922
7 | CERTIFICATION | lxrp_ex322.htm | EX-32.2 | 6020
| Complete submission text file | 0001640334-23-002227.txt |  | 6024342

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA | lxrp-20230831.xsd | EX-101.SCH | 63155
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | lxrp-20230831_lab.xml | EX-101.LAB | 312528
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | lxrp-20230831_cal.xml | EX-101.CAL | 48498
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | lxrp-20230831_pre.xml | EX-101.PRE | 270154
12 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | lxrp-20230831_def.xml | EX-101.DEF | 126498
82 | EXTRACTED XBRL INSTANCE DOCUMENT | lxrp_10k_htm.xml | XML | 1028998

Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 001-39874 | Film No.: 231423628
SIC: 2834 Pharmaceutical Preparations